Harmony Biosciences Holdings Inc

HRMY

Healthcare|Biotechnology|USA

$36.87

-1.38 (-3.61%)

DCF (FCF)

$50.96

Tangible Book

$14.29

Graham Number

$29.30

Earnings Power

$41.99

About

Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The company has one reportable segment: rare neurological diseases. Its product WAKIX (pitolisant) is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and is used for the treatment of cataplexy in adult patients with narcolepsy. The other drug candidates in its pipeline are Pitolisant, HBS-102 (MCHR1 antagonist), BP1.15205 (orexin-2 receptor agonist), ZYN002 (cannabidiol gel), EPX-100 (clemizole hydrochloride), and EPX-200 (lorcaserin), among others.

Stock Price

+7.4%(1Y)

Pipeline Summary

30 total trials

Phase 1

Phase 2

Phase 3

Phase 4

Active: 4Completed: 15NOT_YET_RECRUITING: 1NO_LONGER_AVAILABLE: 1Recruiting: 7Unknown: 1ENROLLING_BY_INVITATION: 1

Active Trials (11)

You, Me and Nature Pilot Study

NCT06451978Dementia

N/AActive

Enrollment: 48 participants

Study Evaluating the Effect of Nutra Harmony "Biotin, Collagen and Keratin Beauty Complex" Dietary Supplement on Hair Thickness and Hair Strength in Adults With Self-Perceived Thinning Hair

NCT07520019Hair Thinning

N/AActive

Enrollment: 40 participants

WAKIX® (Pitolisant) Pregnancy Registry

NCT05536011Pregnancy Related

Recruiting

Enrollment: 1,329 participants

The UPbeating GReek Application of DancE in Parkinson's Disease Clinical Trial

NCT06220084Parkinson Disease

N/AActive

Enrollment: 40 participants

Examining the Effects of Regular Brief Internet-based Meditation Practice on Mental Health and Well Being

NCT06014281Healthy

N/AActive

Enrollment: 300 participants

View all 11 active trials →

BioScore

5/10

Watchlist

Ownership

Recent Insider Trades

Kapadia SandipSELL

2026-01-263,746 shares @ $37.15

Kapadia SandipSELL

2026-01-1520,961 shares @ $35.92

Dayno Jeffrey M.SELL

2025-12-1225,933 shares @ $40.11

Kapadia SandipSELL

2025-12-0520,000 shares @ $39.54

Kapadia SandipSELL

2025-11-213,427 shares @ $35

Recent News

2026-06-30 17:40:15

Data last updated: Jul 12, 2026, 07:30 PM